Valvular & structural heart diseaseCohort study
Transcatheter Aortic Valve Replacement (TAVR) in Medicare Advantage and Medicare Fee-for-Service: Differences in Patient Characteristics, Utilization, and Outcomes
- cohort
Authors' conclusion
Despite similar clinical profiles and TAVR utilization, MA patients appeared to experience better 30-day and 1-year outcomes than FFS patients. Differences in care delivery may contribute, but future studies are needed to understand differences in outcomes.
Study context
- Population
- Medicare patients who underwent TAVR from January 1, 2018, to December 31, 2022patients undergoing TAVR (64.4% fee-for-service (FFS), 35.6% Medicare Advantage (MA))
- Participants
- 317,630 patients
- Exposure
- MA versus FFS enrollment
Main finding
As reported in the abstract
TAVR utilization rate · by the end of the study
Observational data: associations, not effects.
Further findings
Black race · MA patients more likely to be Black
SMD −11.9
Dual-enrolled in Medicaid · MA patients more likely to be dual-enrolled
SMD −16.3
| Outcome | Estimate | |
|---|---|---|
| Death · 30-day · comorbidity-adjusted model | adjusted odds ratio 0.90 (95% CI 0.86–0.95) | |
| Death, all-cause readmission, stroke, aortic valve reintervention · 1 year · death | hazard ratio 0.94 (95% CI 0.92–0.96) | |
| Death, all-cause readmission, stroke, aortic valve reintervention · 1 year · all-cause readmission | hazard ratio 0.86 (95% CI 0.85–0.88) | |
| Death, all-cause readmission, stroke, aortic valve reintervention · 1 year · stroke | hazard ratio 0.90 (95% CI 0.87–0.94) | |
| Death, all-cause readmission, stroke, aortic valve reintervention · 1 year · aortic valve reintervention | hazard ratio 0.86 (95% CI 0.76–0.96) | |
| 0.512Ratio (log scale) |
Comorbidity profiles
- Similar
- SMD, < 10
Baseline characteristics
- mean age
- 80.6±7.0 years
- male
- 55.1%
Original publication
Transcatheter Aortic Valve Replacement (TAVR) in Medicare Advantage and Medicare Fee-for-Service: Differences in Patient Characteristics, Utilization, and Outcomes. Circ Popul Health Outcomes. Published 30 September 2026. doi:10.1161/circoutcomes.126.013591
Summarised from the published abstract; every number is checked against it